Skip to main content

Table 1 Total cholesterol and ALT in blood samples increased after topical dexamethasone treatment. Blood samples were analyzed after 4 weeks of treatment. All data are expressed as the mean ± standard deviation (N = 6)

From: Topical ocular dexamethasone decreases intraocular pressure and body weight in rats

Terms

Unit

Vehicle

DEX

p value

Albumin

(g/dL)

4.15 ± 0.12

4.05 ± 0.36

0.5359

ALP

(IU/L)

525.5 ± 74.9

656.8 ± 169

0.117

ALT (GPT)

(IU/L)

57.0 ± 23.1

190.7 ± 169

0.0197

AST (GOT)

(IU/L)

93.5 ± 23.4

164.7 ± 89.8

0.0897

Calcium

(mg/dL)

10.3 ± 0.32

10.1 ± 0.35

0.29

Chloride

(mEQ/L)

102.0 ± 1.91

101.0 ± 1.67

0.2487

Cholineesterase

(IU/L)

6.83 ± 2.04

5.50 ± 0.55

0.1533

Creatinine

(mg/dL)

0.26 ± 0.03

0.20 ± 0.04

0.0132

Free fatty acid

(μEQ/L)

176.7 ± 80.0

382.7 ± 245.6

0.0793

Glucose

(mg/dL)

169.7 ± 13.2

166.2 ± 57.9

0.888

HbA1c (NGSP)

(%)

4.87 ± 0.37

5.55 ± 0.92

0.12234

Inorganic phosphorus

(mg/dL)

7.57 ± 0.56

8.30 ± 1.67

0.331

Potassium

(mEQ/L)

4.78 ± 0.50

4.82 ± 1.08

0.9466

Sodium

(mEQ/L)

143.8 ± 0.98

145.2 ± 1.60

0.1129

Total cholesterol

(mg/dL)

70.0 ± 16.8

230.5 ± 37.6

<0.0001

Total protein

(g/dL)

6.23 ± 0.32

6.35 ± 0.37

0.5739

Triglyceride

(mg/dL)

165.2 ± 63.3

208.2 ± 47.2

0.2119

Urea nitrogen

(mg/dL)

18.62 ± 1.56

19.28 ± 2.42

0.583

γ – GTP

(IU/L)

<3

<3

 
  1. ALP alkaline phosphatase, ALT, alanine transaminase, GPT glutamic pyruvic transaminase, AST aspartate aminotransferase, GOT glutamic oxaloacetic transaminase, HbA1c glycated hemoglobin, γ-GTP gamma-glutamyl transpeptidase
  2. Bold data represent the term that have significantly difference between control and dex treatment